BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 37266588)

  • 1. Harnessing three-dimensional (3D) cell culture models for pulmonary infections: State of the art and future directions.
    Shah DD; Raghani NR; Chorawala MR; Singh S; Prajapati BG
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2861-2880. PubMed ID: 37266588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Complete Multi-Cell Type Lung Organoids From Human Embryonic and Patient-Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation.
    Leibel SL; McVicar RN; Winquist AM; Niles WD; Snyder EY
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e118. PubMed ID: 32640120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Term Culture of Human Kidney Proximal Tubule Epithelial Cells Maintains Lineage Functions and Serves as an Ex vivo Model for Coronavirus Associated Kidney Injury.
    Xia S; Wu M; Chen S; Zhang T; Ye L; Liu J; Li H
    Virol Sin; 2020 Jun; 35(3):311-320. PubMed ID: 32602046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening.
    Kronemberger GS; Carneiro FA; Rezende DF; Baptista LS
    Artif Organs; 2021 Jun; 45(6):548-558. PubMed ID: 33264436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iPSC-derived three-dimensional brain organoid models and neurotropic viral infections.
    Swingler M; Donadoni M; Bellizzi A; Cakir S; Sariyer IK
    J Neurovirol; 2023 Apr; 29(2):121-134. PubMed ID: 37097597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models.
    Lee SW; Jung DJ; Jeong GS
    Tissue Eng Regen Med; 2020 Dec; 17(6):731-745. PubMed ID: 32207030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells.
    Dawoody Nejad L; Julian LM
    Mol Biol Rep; 2023 Dec; 50(12):10627-10635. PubMed ID: 37740859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay of cells, polymers, and vascularization in three-dimensional lung models and their applications in COVID-19 research and therapy.
    Ahmed TA; Eldaly B; Eldosuky S; Elkhenany H; El-Derby AM; Elshazly MF; El-Badri N
    Stem Cell Res Ther; 2023 Apr; 14(1):114. PubMed ID: 37118810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-Dimensional Cell Culture Models to Study Respiratory Virus Infections Including COVID-19.
    Harb A; Fakhreddine M; Zaraket H; Saleh FA
    Biomimetics (Basel); 2021 Dec; 7(1):. PubMed ID: 35076456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models.
    Basu A; Pamreddy A; Singh P; Sharma K
    J Mol Biol; 2022 Feb; 434(3):167213. PubMed ID: 34437890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung-on-chip.
    Dichtl S; Posch W; Wilflingseder D
    Eur J Immunol; 2024 Mar; 54(3):e2250356. PubMed ID: 38361030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery.
    de Dios-Figueroa GT; Aguilera-Marquez JDR; Camacho-Villegas TA; Lugo-Fabres PH
    Biomedicines; 2021 May; 9(6):. PubMed ID: 34073231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling.
    Csöbönyeiová M; Klein M; Kuniaková M; Varga I; Danišovič Ľ
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection.
    Ni K; Che B; Yang C; Qin Y; Gu R; Wang C; Luo M; Deng L
    Front Pharmacol; 2022; 13():1033043. PubMed ID: 36578545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics.
    Plebani R; Bai H; Si L; Li J; Zhang C; Romano M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway and Alveoli Organoids as Valuable Research Tools in COVID-19.
    de Oliveira M; De Sibio MT; Costa FAS; Sakalem ME
    ACS Biomater Sci Eng; 2021 Aug; 7(8):3487-3502. PubMed ID: 34288642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D tissue-engineered lung models to study immune responses following viral infections of the small airways.
    Do T; Synan L; Ali G; Gappa-Fahlenkamp H
    Stem Cell Res Ther; 2022 Sep; 13(1):464. PubMed ID: 36071442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological aspects and pharmacological applications of three-dimensional cancer cell cultures and organoids.
    Foglietta F; Canaparo R; Muccioli G; Terreno E; Serpe L
    Life Sci; 2020 Aug; 254():117784. PubMed ID: 32416169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional models of the lung: past, present and future: a mini review.
    Sen C; Freund D; Gomperts BN
    Biochem Soc Trans; 2022 Apr; 50(2):1045-1056. PubMed ID: 35411381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.